Literature DB >> 8881250

Trisacryl gelatin microspheres for therapeutic embolization, I: development and in vitro evaluation.

A Laurent1, R Beaujeux, M Wassef, D Rüfenacht, E Boschetti, J J Merland.   

Abstract

PURPOSE: To develop a precisely calibrated, perfectly spherical, stainable, soft, and implantable but nonresorbable particulate embolization material.
METHODS: Calibrated particles with a trisacryl gelatin polymer core and hydrophilic surface characteristics were obtained by reversed emulsion synthesis followed by application of a wet-sieving technique. Particles were suspended in saline, bottled, and sterilized. Quality control included analysis of particle diameters before and after sieving and of suspension sterility and apyrogenicity. Particles were subsequently tested to ascertain their compatibility with commercially available microcatheters.
RESULTS: The resulting embolization material consisted of spherical, stainable microspheres of medical grade with diameters ranging from 130 microns to 1200 microns. Sieving the suspension produced particle groups of homogeneous size (accuracy, +/- 20-100 microns). At injection, the particles showed no tendency to build aggregates or to obstruct the microcatheters.
CONCLUSION: Precisely calibrated and easy-to-use microspheres were obtained that satisfied the biomedical requirements for implantation as an embolization material.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8881250      PMCID: PMC8337995     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  The utility of the microcrystalline cellulose sphere as a particulate embolic agent: an experimental study.

Authors:  Y Kai; J Hamada; M Morioka; T Todaka; S Hasegawa; Y Ushio
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

2.  Newly developed embolic material mesosphere and titanium. Experimental and clinical studies.

Authors:  Y Konishi; E Sato; A Shimada; Y Shiokawa; I Saito; Y Kimura
Journal:  Interv Neuroradiol       Date:  2008-06-09       Impact factor: 1.610

3.  Comparative in vitro evaluation of microspherical embolisation agents.

Authors:  Andrew L Lewis; Clementine Adams; Wendy Busby; Stephen A Jones; Laura C Wolfenden; Simon W Leppard; Rosemary R Palmer; Sharon Small
Journal:  J Mater Sci Mater Med       Date:  2006-12       Impact factor: 3.896

4.  Preparation and characterization of gelatin sponge millispheres from air-in-water-in-oil-type emulsions.

Authors:  Noboru Yamashita; Satoshi Izumikawa; Akira Takagi; Haruyuki Arakawa; Tatsuyoshi Wakasawa; Atsushi Maruyama
Journal:  J Mater Sci Mater Med       Date:  2009-01-10       Impact factor: 3.896

5.  An overview of embolic agents.

Authors:  Sandeep Vaidya; Kathleen R Tozer; Jarvis Chen
Journal:  Semin Intervent Radiol       Date:  2008-09       Impact factor: 1.513

6.  Pharmaceuticals for Intra-arterial Therapy.

Authors:  Aalpen A Patel; Jeffery A Solomon; Michael C Soulen
Journal:  Semin Intervent Radiol       Date:  2005-06       Impact factor: 1.513

7.  Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan.

Authors:  Takao Hiraki; Jun Koizumi; Yasuaki Arai; Yasuo Sakurai; Hiromitsu Kumada; Yoshihiro Nambu; Shinichi Hori
Journal:  Jpn J Radiol       Date:  2015-06-26       Impact factor: 2.374

Review 8.  Advances in Biomaterials and Technologies for Vascular Embolization.

Authors:  Jingjie Hu; Hassan Albadawi; Brian W Chong; Amy R Deipolyi; Rahul A Sheth; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Mater       Date:  2019-06-06       Impact factor: 30.849

9.  Unexpected complications with head and neck hydrogel microsphere particle embolization: A case series and a technical note.

Authors:  Naim N Khoury; Pierre-Olivier Champagne; Marc Kotowski; Jean Raymond; Daniel Roy; Alain Weill
Journal:  Interv Neuroradiol       Date:  2016-10-22       Impact factor: 1.610

10.  Effect of renal embolization with trisacryl and PAVc.

Authors:  Leandro de Assis Barbosa; Jose Guilherme Mendes Pereira Caldas; Mario Luiz Conti; Denise Maria Avancini Costa Malheiros; Francisco Ferreira Ramos
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.